87 related articles for article (PubMed ID: 22335128)
1. [Sleep disorders in the preclinical period of the Alzheimer's disease].
Bidzan L; Grabowski J; Dutczak B; Bidzan M
Psychiatr Pol; 2011; 45(6):851-60. PubMed ID: 22335128
[TBL] [Abstract][Full Text] [Related]
2. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
Bidzan M; Bidzan L
Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component.
Bidzan M; Bidzan L; Pachalska M
Ann Agric Environ Med; 2014; 21(2):412-5. PubMed ID: 24959800
[TBL] [Abstract][Full Text] [Related]
4. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease.
Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Cieslukowska A; Pufal A
Med Sci Monit; 2008 Sep; 14(9):CR473-9. PubMed ID: 18758418
[TBL] [Abstract][Full Text] [Related]
6. [Vascular factors and the psychopathological picture in Alzheimer's disease].
Idzan LB; Bidzan M
Psychiatr Pol; 2006; 40(5):823-31. PubMed ID: 17217228
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
9. [Frequency and intensity of behavioral and psychological symptoms in the course of Alzheimer's disease].
Wasiak B; Gabryelewicz T; Łuczywek E; Pfeffer A; Czyzewski K; Styczyńska M; Gołebiowski M; Matysiak W; Barcikowska M
Psychiatr Pol; 2001; 35(1):93-107. PubMed ID: 11324386
[TBL] [Abstract][Full Text] [Related]
10. [The psychopathological symptoms of the preclinical stages of Alzheimer's disease].
Bidzan L
Psychiatr Pol; 2001; 35(6):1019-32. PubMed ID: 11877882
[TBL] [Abstract][Full Text] [Related]
11. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
12. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
Mizuno S; Kameda A; Inagaki T; Horiguchi J
Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
[TBL] [Abstract][Full Text] [Related]
13. Sleep disturbance in mild to moderate Alzheimer's disease.
Moran M; Lynch CA; Walsh C; Coen R; Coakley D; Lawlor BA
Sleep Med; 2005 Jul; 6(4):347-52. PubMed ID: 15978517
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
Hsieh CJ; Chang CC; Lin CC
Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
[TBL] [Abstract][Full Text] [Related]
15. Daytime sleepiness in mild Alzheimer's disease with and without parkinsonian features.
Park M; Shah RC; Fogg LF; Wyatt JK
Sleep Med; 2011 Apr; 12(4):397-402. PubMed ID: 21388877
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment.
García-Alberca JM; Lara JP; Cruz B; Garrido V; Gris E; Barbancho MÁ
J Nerv Ment Dis; 2013 Mar; 201(3):251-7. PubMed ID: 23407210
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
[TBL] [Abstract][Full Text] [Related]
18. Detecting depression in Alzheimer's disease: evaluation of four different scales.
Müller-Thomsen T; Arlt S; Mann U; Mass R; Ganzer S
Arch Clin Neuropsychol; 2005 Mar; 20(2):271-6. PubMed ID: 15708735
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
20. [Vascular factors and progression of cognitive decline in elderly people].
Bidzan L; Bidzan M
Psychiatr Pol; 2005; 39(5):987-95. PubMed ID: 16358597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
